Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance
- Status
- RECRUITING
- Phase
- PHASE2
Bleeding in Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Study on the Clinical Efficacy of Teclistamab
- Status
- RECRUITING
- Phase
- N/A
Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma
- Status
- RECRUITING
- Phase
- NA
A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03)
- Status
- RECRUITING
- Phase
- PHASE3
Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not
- Status
- RECRUITING
- Phase
- N/A
Talquetamab & Lenalidomide as Post Stem Cell Transplant Maintenance in Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Outcomes and Prognostic Factors in Multiple Myeloma Patients
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Telehealth-based Symptom Management for Veterans Treated With Selinexor
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Evaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC Transplantation
- Status
- COMPLETED
- Phase
- PHASE4
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE3
Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation.
- Status
- RECRUITING
- Phase
- NA
Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection
- Status
- RECRUITING
- Phase
- PHASE4
Study of CT071 Injection in High Risk Newly Diagnosed Multiple Myeloma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
PET Imaging Study of 68Ga-NB381 in Multiple Myeloma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
An Clinical Study of NKG2D-CAR-NK Cells for the Treatment of Refractory Recurrent Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1